Exact Mass: 588.2934
Exact Mass Matches: 588.2934
Found 500 metabolites which its exact mass value is equals to given mass value 588.2934
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Dinoflagellate luciferin
A member of the class of bilenes that is 1,2,3,21-tetrahydro-5,7-ethanobilene-a-19(16H),5(2)-dione which is substituted at positions 2, 8, 13 and 18 by methyl groups and at positions 1, 3, 12 and 17 by carboxy, 2-carboxyethyl, ethyl and vinyl groups, respectively (the 1S,2S,3S diastereoisomer).
8,12-Diethylbacteriochlorophyllide d
Sandoricin
Sandoricin is found in fruits. Sandoricin is a constituent of Sandoricum koetjape (santol). Constituent of Sandoricum koetjape (santol). Sandoricin is found in fruits.
(1RS,2RS)-2-(4-Hydroxyphenyl)-2-methyl-1-(9-(4,4,5,5,5-pentafluoropentyl)sulfinylnonyl)-1,2,3,4-tetrahydronaphth-6-ol
Cfp-aaf-pab
Cilengitide
N(2)-(4-Hydroxy-1-(1-methyl-1H-indol-3-yl)carbonyl-L-prolyl)-N-methyl-N-phenylmethyl-3-(2-naphthyl)-L-alaninamide
Flupentixol decanoate
Synechoxanthin
D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids
16beta-O-acetyl-proscillaridin A|3-O-alpha-L-Rhamnopyranoside,16-Ac-3,14,16-Trohydroxybufa-4,20,22-trienolide
9-Deacetyl-9-benzoyl-10-debenzoyl-4beta,20-epoxytaxchinin A
12-CinnMOYL,20-Ac-Pregnane-3,5,6,8,12,14,17,20-octol
elaeodendroside T
A steroid lactone isolated from Elaeodendron tangenala and exhibits antiproliferative activity against A2780 human ovarian cancer cells. D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides
12??-Acetoxy-3??-hydroxy-24,25,26,27-tetranorcycloart-7-en-23,16??-olide 3-O-??-D-xylopyranoside
2,5,8-Tris(2-methylpropanoyl)-7(14)-bisabolene-1,2,3,4,5,8,10,11-octol
31,32(?)-Didehydro-(R,R)-urobilin; Hydrochlorid|31,32(?)-didehydro-(R,R)-urobilin; hydrochloride
3,3-Dimethyl-5,5-diprenyl-6,6-dimethoxy-1,1-bi[9H-carbazole]-2,2-diol
pre-schisanartanin|pre-schisanartanin A|preschisanartanin A
5alpha-acetyl-1beta,8alpha-bis-cinnamoyl-4alpha-hydroxydihydroagarofuran|5??-Acetyl-1??,8??-bis-cinnamoyl-4??-hydroxydihydroagarofuran
5beta-hydroxyresiniferonol-6alpha,7alpha-epoxy-12beta-acetoxy-9,13,14-ortho-2E-decenoate
Tyr Asn His Arg
C31H40O11_7,11-Methano-2H,4H-oxireno[1,8]cycloocta[1,2-f][2]benzopyran-8-acetic acid, 4-(3-furanyl)dodecahydro-alpha,11-dihydroxy-4a,7,9,9-tetramethyl-10-(2-methyl-1-oxopropoxy)-2,13-dioxo-, methyl ester, (alphaR,4R,4aR,7S,8S,10S,11S,11aR,12aS)
(1S,2R,4S,9R,10R,14S,15S,17S)-9-(furan-3-yl)-1-hydroxy-15-[(1R)-1-hydroxy-2-methoxy-2-oxoethyl]-10,14,16,16-tetramethyl-7,18-dioxo-3,8-dioxapentacyclo[12.3.1.0²,⁴.0⁴,¹³.0⁵,¹⁰]octadecan-17-yl 2-methylpropanoate
(1S,2R,4S,9R,10R,14S,15S,17S)-9-(furan-3-yl)-1-hydroxy-15-[(1R)-1-hydroxy-2-methoxy-2-oxoethyl]-10,14,16,16-tetramethyl-7,18-dioxo-3,8-dioxapentacyclo[12.3.1.0²,⁴.0⁴,¹³.0⁵,¹⁰]octadecan-17-yl 2-methylpropanoate_major
(1S,2R,4S,9R,10R,14S,15S,17S)-9-(furan-3-yl)-1-hydroxy-15-[(1R)-1-hydroxy-2-methoxy-2-oxoethyl]-10,14,16,16-tetramethyl-7,18-dioxo-3,8-dioxapentacyclo[12.3.1.0²,?.0?,¹³.0?,¹?]octadecan-17-yl 2-methylpropanoate
Asp Ile Arg Trp
Asp Ile Trp Arg
Asp Leu Arg Trp
Asp Leu Trp Arg
Asp Arg Ile Trp
Asp Arg Leu Trp
Asp Arg Trp Ile
Asp Arg Trp Leu
Asp Trp Ile Arg
Asp Trp Leu Arg
Asp Trp Arg Ile
Asp Trp Arg Leu
Glu Glu Arg Arg
Glu Phe Phe Phe
Glu Arg Glu Arg
Glu Arg Arg Glu
Glu Arg Val Trp
Glu Arg Trp Val
Glu Val Arg Trp
Glu Val Trp Arg
Glu Trp Arg Val
Glu Trp Val Arg
Phe Glu Phe Phe
Phe Phe Glu Phe
Phe Phe Phe Glu
Phe Phe Ile Tyr
Phe Phe Leu Tyr
Phe Phe Tyr Ile
Phe Phe Tyr Leu
Phe Ile Phe Tyr
Phe Ile Tyr Phe
Phe Leu Phe Tyr
Phe Leu Tyr Phe
Phe Pro Tyr Tyr
Phe Tyr Phe Ile
Phe Tyr Phe Leu
Phe Tyr Ile Phe
Phe Tyr Leu Phe
Phe Tyr Pro Tyr
Phe Tyr Tyr Pro
His Asn Arg Tyr
His Asn Tyr Arg
His Arg Asn Tyr
His Arg Tyr Asn
His Tyr Asn Arg
His Tyr Arg Asn
Ile Asp Arg Trp
Ile Asp Trp Arg
Ile Phe Phe Tyr
Ile Phe Tyr Phe
Ile Met Tyr Tyr
Ile Arg Asp Trp
Ile Arg Trp Asp
Ile Trp Asp Arg
Ile Trp Arg Asp
Ile Tyr Phe Phe
Ile Tyr Met Tyr
Ile Tyr Tyr Met
Lys Gln Gln Trp
Lys Gln Trp Gln
Lys Trp Gln Gln
Leu Asp Arg Trp
Leu Asp Trp Arg
Leu Phe Phe Tyr
Leu Phe Tyr Phe
Leu Met Tyr Tyr
Leu Arg Asp Trp
Leu Arg Trp Asp
Leu Trp Asp Arg
Leu Trp Arg Asp
Leu Tyr Phe Phe
Leu Tyr Met Tyr
Leu Tyr Tyr Met
Met Ile Tyr Tyr
Met Leu Tyr Tyr
Met Pro Arg Trp
Met Pro Trp Arg
Met Arg Pro Trp
Met Arg Trp Pro
Met Trp Pro Arg
Met Trp Arg Pro
Met Tyr Ile Tyr
Met Tyr Leu Tyr
Met Tyr Tyr Ile
Met Tyr Tyr Leu
Asn His Arg Tyr
Asn His Tyr Arg
Asn Asn Arg Trp
Asn Asn Trp Arg
Asn Arg His Tyr
Asn Arg Asn Trp
Asn Arg Trp Asn
Asn Arg Tyr His
Asn Trp Asn Arg
Asn Trp Arg Asn
Asn Tyr His Arg
Asn Tyr Arg His
Pro Phe Tyr Tyr
Pro Met Arg Trp
Pro Met Trp Arg
Pro Arg Met Trp
Pro Arg Trp Met
Pro Thr Trp Trp
Pro Trp Met Arg
Pro Trp Arg Met
Pro Trp Thr Trp
Pro Trp Trp Thr
Pro Tyr Phe Tyr
Pro Tyr Tyr Phe
Gln Lys Gln Trp
Gln Lys Trp Gln
Gln Gln Lys Trp
Gln Gln Gln Trp
Gln Gln Trp Lys
Gln Gln Trp Gln
Gln Trp Lys Gln
Gln Trp Gln Lys
Gln Trp Gln Gln
Arg Asp Ile Trp
Arg Asp Leu Trp
Arg Asp Trp Ile
Arg Asp Trp Leu
Arg Glu Glu Arg
Arg Glu Arg Glu
Arg Glu Val Trp
Arg Glu Trp Val
Arg His Asn Tyr
Arg His Tyr Asn
Arg Ile Asp Trp
Arg Ile Trp Asp
Arg Leu Asp Trp
Arg Leu Trp Asp
Arg Met Pro Trp
Arg Met Trp Pro
Arg Asn His Tyr
Arg Asn Asn Trp
Arg Asn Trp Asn
Arg Asn Tyr His
Arg Pro Met Trp
Arg Pro Trp Met
Arg Arg Glu Glu
Arg Val Glu Trp
Arg Val Trp Glu
Arg Trp Asp Ile
Arg Trp Asp Leu
Arg Trp Glu Val
Arg Trp Ile Asp
Arg Trp Leu Asp
Arg Trp Met Pro
Arg Trp Asn Asn
Arg Trp Pro Met
Arg Trp Val Glu
Arg Tyr His Asn
Arg Tyr Asn His
Thr Pro Trp Trp
Thr Trp Pro Trp
Thr Trp Trp Pro
Val Glu Arg Trp
Val Glu Trp Arg
Val Arg Glu Trp
Val Arg Trp Glu
Val Val Trp Trp
Val Trp Glu Arg
Val Trp Arg Glu
Val Trp Val Trp
Val Trp Trp Val
Trp Asp Ile Arg
Trp Asp Leu Arg
Trp Asp Arg Ile
Trp Asp Arg Leu
Trp Glu Arg Val
Trp Glu Val Arg
Trp Ile Asp Arg
Trp Ile Arg Asp
Trp Lys Gln Gln
Trp Leu Asp Arg
Trp Leu Arg Asp
Trp Met Pro Arg
Trp Met Arg Pro
Trp Asn Asn Arg
Trp Asn Arg Asn
Trp Pro Met Arg
Trp Pro Arg Met
Trp Pro Thr Trp
Trp Pro Trp Thr
Trp Gln Lys Gln
Trp Gln Gln Lys
Trp Gln Gln Gln
Trp Arg Asp Ile
Trp Arg Asp Leu
Trp Arg Glu Val
Trp Arg Ile Asp
Trp Arg Leu Asp
Trp Arg Met Pro
Trp Arg Asn Asn
Trp Arg Pro Met
Trp Arg Val Glu
Trp Thr Pro Trp
Trp Thr Trp Pro
Trp Val Glu Arg
Trp Val Arg Glu
Trp Val Val Trp
Trp Val Trp Val
Trp Trp Pro Thr
Trp Trp Thr Pro
Trp Trp Val Val
Tyr Phe Phe Ile
Tyr Phe Phe Leu
Tyr Phe Ile Phe
Tyr Phe Leu Phe
Tyr Phe Pro Tyr
Tyr Phe Tyr Pro
Tyr His Asn Arg
Tyr His Arg Asn
Tyr Ile Phe Phe
Tyr Ile Met Tyr
Tyr Ile Tyr Met
Tyr Leu Phe Phe
Tyr Leu Met Tyr
Tyr Leu Tyr Met
Tyr Met Ile Tyr
Tyr Met Leu Tyr
Tyr Met Tyr Ile
Tyr Met Tyr Leu
Tyr Asn Arg His
Tyr Pro Phe Tyr
Tyr Pro Tyr Phe
Tyr Arg His Asn
Tyr Arg Asn His
Tyr Tyr Phe Pro
Tyr Tyr Ile Met
Tyr Tyr Leu Met
Tyr Tyr Met Ile
Tyr Tyr Met Leu
Tyr Tyr Pro Phe
Sandoricin
(2aR,3R,6bS,7aR,8S,9S,11S,12S)-3-(furan-3-yl)-8-hydroxy-11-((R)-1-hydroxy-2-methoxy-2-oxoethyl)-2a,10,10,12-tetramethyl-5,13-dioxododecahydro-2H,3H-8,12-methanooxireno[2,3:1,8]cycloocta[1,2-f]isochromen-9-yl isobutyrate
Flupentixol decanoate
D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist
5-[2,5-bis[2-(1,3,3-trimethylindol-2-ylidene)ethylidene]cyclopentylidene]-1,3-dimethyl-1,3-diazinane-2,4,6-trione
Cilengitide
C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C2144 - Endothelial-Specific Integrin/Survival Signaling Inhibitor D009676 - Noxae > D011042 - Poisons > D014688 - Venoms
(S)-2-[(S)-2-((S)-1-Ethoxycarbonyl-3-phenylpropylamino)propionyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid benzyl ester
Procaine penicillin
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
Flupentixol decanoate, (Z)-
D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants
(2S,4R)-N-[(2S)-1-[benzyl(methyl)amino]-3-naphthalen-2-yl-1-oxopropan-2-yl]-4-hydroxy-1-(1-methylindole-3-carbonyl)pyrrolidine-2-carboxamide
2-[(8S,11S)-11-{(1R)-1-Hydroxy-2-[isopentyl(phenylsulfonyl)amino]ethyl}-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-8-YL]acetamide
3-[2-[[3-(2-carboxylatoethyl)-5-[(3-ethyl-4-methyl-5-oxo-1,2-dihydropyrrol-2-yl)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(4-ethenyl-3-methyl-5-oxo-1,2-dihydropyrrol-2-yl)methyl]-4-methyl-1H-pyrrol-3-yl]propanoate
(1RS,2RS)-2-(4-Hydroxyphenyl)-2-methyl-1-(9-(4,4,5,5,5-pentafluoropentyl)sulfinylnonyl)-1,2,3,4-tetrahydronaphth-6-ol
Methyl 2-[(1S,3S,5S,7S,8S,9R,11S,12S,13R,16S)-5,11-diacetyloxy-13-(furan-3-yl)-16-hydroxy-6,6,8,12-tetramethyl-17-methylidene-15-oxo-2,14-dioxatetracyclo[7.7.1.01,12.03,8]heptadecan-7-yl]acetate
(3R)-2-[(R)-tert-butylsulfinyl]-N-cyclobutyl-4-[3-[4-(dimethylcarbamoyl)phenyl]phenyl]-3-(2-hydroxyethyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
N-[(2S,3R)-2-[[[(1,3-benzodioxol-5-ylamino)-oxomethyl]-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-phenylacetamide
N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(1-naphthalenylamino)-oxomethyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-oxanecarboxamide
N-[(2R,3R)-2-[[[(1,3-benzodioxol-5-ylamino)-oxomethyl]-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-phenylacetamide
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[[(4-methoxyanilino)-oxomethyl]-methylamino]methyl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[[(4-methoxyanilino)-oxomethyl]-methylamino]methyl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide
N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[[(4-methoxyanilino)-oxomethyl]-methylamino]methyl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide
N-[(2R,3S)-2-[[[(1,3-benzodioxol-5-ylamino)-oxomethyl]-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-phenylacetamide
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(1-naphthalenylamino)-oxomethyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-oxanecarboxamide
N-[(2R,3R)-2-[[[(1,3-benzodioxol-5-ylamino)-oxomethyl]-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-phenylacetamide
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(1-naphthalenylamino)-oxomethyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-oxanecarboxamide
N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(1-naphthalenylamino)-oxomethyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-oxanecarboxamide
N-[(2S,3S)-2-[[[(1,3-benzodioxol-5-ylamino)-oxomethyl]-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-phenylacetamide
N-[(2S,3R)-2-[[[(1,3-benzodioxol-5-ylamino)-oxomethyl]-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-phenylacetamide
N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(1-naphthalenylamino)-oxomethyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-oxanecarboxamide
N-[(2R,3S)-2-[[benzenesulfonyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide
N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-2-[[[(4-methoxyanilino)-oxomethyl]-methylamino]methyl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide
N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-2-[[[(4-methoxyanilino)-oxomethyl]-methylamino]methyl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide
N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[[(4-methoxyanilino)-oxomethyl]-methylamino]methyl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-2-[[[(4-methoxyanilino)-oxomethyl]-methylamino]methyl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide
(3S)-2-[(S)-tert-butylsulfinyl]-N-cyclobutyl-4-[3-[4-[dimethylamino(oxo)methyl]phenyl]phenyl]-3-(2-hydroxyethyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
[1-[(2-heptanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
[1-hydroxy-3-[hydroxy-(3-hydroxy-2-propanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate
[1-hydroxy-3-[hydroxy-(3-hydroxy-2-pentanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate
[(1S,2R,4S,5R,9R,10R,14S,15S,17S)-9-(furan-3-yl)-1-hydroxy-15-[(1R)-1-hydroxy-2-methoxy-2-oxoethyl]-10,14,16,16-tetramethyl-7,18-dioxo-3,8-dioxapentacyclo[12.3.1.02,4.04,13.05,10]octadecan-17-yl] 2-methylpropanoate
Bemfivastatin
Bemfivastatin (PPD 10558) is an orally active, HMG-CoA Reductase (HMGCR) inhibitor, also known as Statin. Bemfivastatin enhances the activity of liver extraction. Bemfivastatin exhibits little developmental toxicity effects in pregnant rats and rabbits via daily oral doses during organogenesis period. The no observed adverse effect level (NOAEL) are ≥320?mg/kg/day for rats developmental toxicity, 12.5?mg/kg/day for rabbits maternal toxicity, and 25?mg/kg/day for rabbits developmental toxicity, respectively. Bemfivastatin can be used for research on Statin-related hypercholesterolemic myalgia with inability to tolerate statins[1][2].
4-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-18-(4-carboxy-2,3-dimethylphenyl)-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]-2,3-dimethylbenzoic acid
(1s,3as,5ar,7r,8s,9ar,9br,10r,11ar)-3a,7,8,10-tetrahydroxy-1-[(2r,4r,5r)-2-[5-(hydroxymethyl)furan-2-yl]-4-methyl-5-(3-methylbutyl)-1,3-dioxolan-4-yl]-9a,11a-dimethyl-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one
(1r,2s,3s,5s,8r,9s,10r,11s,13r,16s)-11,16-bis(acetyloxy)-5,8,9-trihydroxy-3-(2-hydroxypropan-2-yl)-6,10-dimethyl-14-oxatetracyclo[8.6.0.0³,⁷.0¹³,¹⁶]hexadec-6-en-2-yl benzoate
methyl 2-[(1s,3r,4s,5s,7s,8s,9r,12s,13s,16s)-4,16-bis(acetyloxy)-13-(furan-3-yl)-5-hydroxy-6,6,8,12-tetramethyl-17-methylidene-15-oxo-2,14-dioxatetracyclo[7.7.1.0¹,¹².0³,⁸]heptadecan-7-yl]acetate
(1s,2r,4s,5r,9r,10r,13r,14s,15s,17s)-9-(furan-3-yl)-1-hydroxy-15-[(1r)-1-hydroxy-2-methoxy-2-oxoethyl]-10,14,16,16-tetramethyl-7,18-dioxo-3,8-dioxapentacyclo[12.3.1.0²,⁴.0⁴,¹³.0⁵,¹⁰]octadecan-17-yl 2-methylpropanoate
(1r,2s,3r,10s,19r,22s,23s,24r,26r,29r)-10-acetyl-1,22-dihydroxy-2,22-dimethyl-5,16-dioxo-4,11,17,25-tetraoxahexacyclo[21.3.1.1³,²⁶.1¹⁰,¹⁴.0²,¹⁹.0¹⁹,²⁴]nonacosa-6,14-dien-29-yl acetate
3-{4,10-dihydroxy-2-methoxy-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-6-hydroxy-7,7-dimethyl-5-oxooxepan-2-yl acetate
4,6,12,17,17-pentamethyl-8-oxo-18-[(3,4,5-trihydroxyoxan-2-yl)oxy]-9-oxahexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docos-13-en-3-yl acetate
21-hexyl-9,10,17-trihydroxy-5-(hydroxymethyl)-3-methoxy-8,8,12,24-tetramethyl-13,14,22-trioxapentacyclo[14.6.2.0²,¹².0⁶,⁹.0¹⁹,²³]tetracosa-4,16,18,23-tetraen-15-one
(1s,3r,5s,6s,7s,9r,10r,13r,14r,16s,18r,20r,22s,24s,26s)-7,13,26-trihydroxy-1-methoxy-5,9,24-trimethyl-10-(6-oxopyran-3-yl)-2,15,21,23-tetraoxaheptacyclo[20.3.1.0³,²⁰.0⁵,¹⁸.0⁶,¹⁴.0⁹,¹³.0¹⁴,¹⁶]hexacosan-8-one
methyl 2-[4,5-bis(acetyloxy)-12-(furan-3-yl)-6,6,8,11,16-pentamethyl-14,17-dioxo-2,13-dioxatetracyclo[7.6.2.0¹,¹¹.0³,⁸]heptadecan-7-yl]acetate
5α-acetyl-1β,8α-bis-cinnamoyl-4α-hydroxydi-hydroagarofuran
{"Ingredient_id": "HBIN011403","Ingredient_name": "5\u03b1-acetyl-1\u03b2,8\u03b1-bis-cinnamoyl-4\u03b1-hydroxydi-hydroagarofuran","Alias": "NA","Ingredient_formula": "C35H40O8","Ingredient_Smile": "CC(=O)OC1C2CC(C3(C1(C(CCC3OC(=O)C=CC4=CC=CC=C4)(C)O)OC2(C)C)C)OC(=O)C=CC5=CC=CC=C5","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "334","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
7,9,10-deacetylbaccatin vi
{"Ingredient_id": "HBIN012995","Ingredient_name": "7,9,10-deacetylbaccatin vi","Alias": "NA","Ingredient_formula": "C31H40O11","Ingredient_Smile": "CC1=C2C(C(C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C)O)OC(=O)C5=CC=CC=C5)(CO4)OC(=O)C)O)C)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4724","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
7,9,13-trideacetylbaccatin vi
{"Ingredient_id": "HBIN012999","Ingredient_name": "7,9,13-trideacetylbaccatin vi","Alias": "NA","Ingredient_formula": "C31H40O11","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21587","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
7,9-diacetyltaxayuntin
{"Ingredient_id": "HBIN013003","Ingredient_name": "7,9-diacetyltaxayuntin","Alias": "NA","Ingredient_formula": "C31H40O11","Ingredient_Smile": "CC1=C2C(C(C3(C(CC4C(C3C(C2(CC1O)C(C)(C)O)OC(=O)C)(CO4)OC(=O)C)O)C)O)OC(=O)C5=CC=CC=C5","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15014","TCMID_id": "5347","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
7-epi-9,10-deacetylbaccatin vi
{"Ingredient_id": "HBIN013170","Ingredient_name": "7-epi-9,10-deacetylbaccatin vi","Alias": "NA","Ingredient_formula": "C31H40O11","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6880","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
arteminolide b
{"Ingredient_id": "HBIN016946","Ingredient_name": "arteminolide b","Alias": "NA","Ingredient_formula": "C35H40O8","Ingredient_Smile": "CC1=C2C(C3C(C(C1)OC(=O)C=C(C)C)C4(CC56C=CC4(C5C7C(CCC6(C)O)C(=C)C(=O)O7)C)C(=O)O3)C(=CC2=O)C","Ingredient_weight": "588.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1790","TCMSP_id": "NA","TCM_ID_id": "10104;10105;10106;10107;16347;16348","PubChem_id": "24941963","DrugBank_id": "NA"}
arteminolide d
{"Ingredient_id": "HBIN016948","Ingredient_name": "arteminolide d","Alias": "NA","Ingredient_formula": "C35H40O8","Ingredient_Smile": "CC=C(C)C(=O)OC1CC(=C2C(C3C1C4(CC56C=CC4(C5C7C(CCC6(C)O)C(=C)C(=O)O7)C)C(=O)O3)C(=CC2=O)C)C","Ingredient_weight": "588.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1791","TCMSP_id": "NA","TCM_ID_id": "10110;10111;10112;10113;16349;16350","PubChem_id": "24941966","DrugBank_id": "NA"}